Skip to content
Trial Eligibility
Menu

BLOOM: Biological Legacy of Origin in Mother-Infant Dyads

NCT02000895

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Infants born preterm and of low birth weight are known to be at increased risk for early onset of cardiovascular and renal disease in adult life. This has been related to low nephron mass due to inadequate or early termination of glomerulogenesis in utero and during the perinatal period. Risks for subsequent development of hypertension and kidney disease include proteinuria, excessive weight gain during early life with insulin resistance and supplemental high calorie feedings.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Chronic Kidney Diseases
  • Cardiovascular Diseases

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
Up to 10 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
University of Miami
Last updated on ClinicalTrials.gov
March 16, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Florida · 1

  • University of Miami/ Holtz Children's Hospital · Miami, FL

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.